(Q37311057)

19 August 2017

A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF. (English)

1 reference

19 August 2017

1 reference

1 reference

Zhiming Hu

1

1 reference

19 August 2017

Wanlong Tan

2

1 reference

19 August 2017

Lin Zhang

3

1 reference

19 August 2017

Zhongkun Liang

4

1 reference

19 August 2017

Cuixiang Xu

5

1 reference

19 August 2017

Hua Su

6

1 reference

19 August 2017

Jianxin Lu

7

1 reference

19 August 2017

Jimin Gao

8

1 reference

19 August 2017

20 July 2009

1 reference

Journal of Cellular and Molecular Medicine

19 August 2017

1 reference

19 August 2017

14

1 reference

19 August 2017

1836-1844

1 reference

19 August 2017

6B

1 reference

History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Gene modification strategies to induce tumor immunity.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Human cancer gene therapy with cytokine gene-modified cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Cancer gene therapy: an awkward adolescence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

GM-CSF-based cancer vaccines

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

BCG immunotherapy of bladder cancer: 20 years on.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

GM-CSF-surface-modified B16.F10 melanoma cell vaccine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Nonviral cytokine gene therapy on an orthotopic bladder cancer model.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829043

Pretargeted radioimmunotherapy

2 September 2018

1 reference

12 December 2020

A new approach in the management of urothelial tumors using GM-CSF on marker lesions: an ultrastructural and immunohistochemical study on the macrophage population in bladder mucosa

1 reference

12 December 2020

Recombinant interleukin-2 and lymphokine-activated killer cell treatment of advanced bladder cancer: clinical results and immunological effects

1 reference

12 December 2020

High-dose versus low-dose intravesical interferon-alpha 2b in the treatment of carcinoma in situ: a randomized, controlled study

1 reference

12 December 2020

Streptavidin-containing chimeric proteins: design and production

1 reference

12 December 2020

Recombinant tumor necrosis factor for superficial bladder tumors

1 reference

12 December 2020

10.1111/J.1582-4934.2009.00818.X

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference